Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
National Centre for Asbestos Related Diseases, Medical School, University of Western Australia, Crawley, Western Australia, Australia.
J Thorac Oncol. 2024 Sep;19(9):1310-1325. doi: 10.1016/j.jtho.2024.03.007. Epub 2024 Mar 21.
The primary tumor (T) component in the eighth edition of pleural mesothelioma (PM) staging system is based on pleural involvement and extent of invasion. Quantitative assessment of pleural tumor has been found to be prognostic. We explored quantitative and qualitative metrics to develop recommendations for T descriptors in the upcoming ninth edition of the PM staging system.
The International Association for the Study of Lung Cancer prospectively collected data on patients with PM. Sum of maximum pleural thickness (Psum) was recorded. Optimal combinations of Psum and eighth edition cT descriptors were assessed using recursive binary splitting algorithm, with bootstrap resampling to correct for the adaptive nature of the splitting algorithm, and validated in the eighth edition data. Overall survival (OS) was calculated by the Kaplan-Meier method and differences in OS assessed by the log-rank test.
Of 7338 patients submitted, 3598 were eligible for cT analysis and 1790 had Psum measurements. Recursive partitioning identified optimal cutpoints of Psum at 12 and 30 mm, which, in combination with extent of invasion, yielded four prognostic groups for OS. Fmax greater than 5 mm indicated poor prognosis. cT4 category (based on invasion) revealed similar performance to eighth edition. Three eighth edition descriptors were eliminated based on low predictive accuracy. Eighth edition pT descriptors remained valid in ninth edition analyses.
Given reproducible prognostication by Psum, size criteria will be incorporated into cT1 to T3 categories in the ninth edition. Current cT4 category and all pT descriptors will be maintained, with reclassification of fissural invasion as pT2.
第八版胸膜间皮瘤(PM)分期系统中的主要肿瘤(T)成分基于胸膜受累和侵袭程度。已经发现胸膜肿瘤的定量评估具有预后意义。我们探索了定量和定性指标,以制定即将发布的第九版 PM 分期系统中 T 描述符的建议。
国际肺癌研究协会前瞻性地收集了 PM 患者的数据。记录最大胸膜厚度(Psum)的总和。使用递归二分分裂算法评估 Psum 和第八版 cT 描述符的最佳组合,并通过引导重采样对分裂算法的自适应性质进行校正,然后在第八版数据中进行验证。通过 Kaplan-Meier 方法计算总生存期(OS),并通过对数秩检验评估 OS 的差异。
提交的 7338 例患者中,3598 例符合 cT 分析条件,1790 例有 Psum 测量值。递归分区确定了 Psum 的最佳截断值为 12 和 30mm,与侵袭程度相结合,可将 OS 的预后分为四个组。Fmax 大于 5mm 表明预后不良。基于侵袭的 cT4 类别(基于侵袭)表现出类似的性能。基于低预测准确性,删除了三个第八版描述符。第八版 pT 描述符在第九版分析中仍然有效。
鉴于 Psum 可重复预测预后,大小标准将纳入第九版 cT1 至 T3 类别。目前的 cT4 类别和所有 pT 描述符将保持不变,裂层侵犯重新分类为 pT2。